ASX Announcements
August
Nufarm shares plunge after profit downgrade
The company was hit hard as it backtracks on guidance issued three months ago based on weak prices for farm chemicals and lower than expected returns on omega-3 canola oil.
- Brad Thompson
May
Nufarm boss says he wants even playing field, not handouts
Nufarm chief executive Greg Hunt says other nations treat grain production as a critical industry.
- Brad Thompson
February
Nufarm wants biofuel mandates to send agriculture flying
Nufarm chairman John Gillam says he wants government green fuel mandates to cash in on a “once-in-a-lifetime” opportunity for agriculture.
- Brad Thompson
November 2023
Biofuels finally give GrainCorp an in to Western Australia
Robert Spurway says there’s a compelling case for new oilseed crushing capacity in the company’s biggest move since it spun-off its global malting division.
- Brad Thompson
August 2023
- Opinion
- Agriculture
How to invest in agriculture without buying a farm
The portfolio thesis for investing in agriculture is compelling – this is how to gain exposure.
- James Wright
May 2023
Sowing the seeds of rising dividends at Nufarm
Canola, sorghum and sunflower seeds are in huge demand around the world and ASX-listed Nufarm is making big money from it.
- Simon Evans
February 2023
Nufarm chairman says Albanese team best in years for manufacturing
Nufarm chairman John Gillam says the future of manufacturing in Australia is brighter than many realise under the Albanese government.
- Updated
- Brad Thompson
November 2022
Nufarm says food production just as critical as minerals
The farm chemical supplier made the case for government backing of agriculture-related onshore manufacturing as its shares surged 10 per cent on strong profits.
- Brad Thompson
- Opinion
- Sharemarket
Key stocks to watch after east coast floods
At risk are not only farmers but producers of fertiliser, cheese and even coal.
- Elio D'Amato
September 2022
Farmers run the risk on most expensive wheat crop in history
September 30 marks the end of the agricultural year with farmers sweating on the harvest of the most expensive crop they have ever grown and worried by warnings of softer commodity prices.
- Brad Thompson
June 2022
Buy, hold, sell: Three of the ASX200’s highest returning stocks
Two fund managers share their thoughts on three of the highest returning ASX200 stocks - and two being overlooked.
May 2022
Sumitomo calls time on painful 12-year Nufarm investment, out at $5.38
Australia’s Nufarm has farewelled white knight Sumitomo Chemical Company. The bookbuild, run by Citi, cleared at the $5.38 floor price.
- Updated
- Anthony Macdonald, Sarah Thompson and Kanika Sood
Sumitomo dumps $324m Nufarm stake, Citi on trade
Japan’s Sumitomo Chemical Company is selling its 15.9 per cent stake, ending a 12-year stint at the Australian company.
- Anthony Macdonald, Sarah Thompson and Kanika Sood
Nufarm shares slump as farmers pull sales forward amid uncertainty
Nufarm shares fell despite bumper first half earnings as CEO Greg Hunt flagged farmers had loaded up on crop protection, pulling sales forward.
- Michael Bennet
February 2022
All the profit results for February 3, 2022
Results briefing | News and analysis on today’s profit results from Westpac, Nick Scali, Nufarm, Emeco, and Cettire. Find updated reports and analysis here.
- Updated
- Andrew Hobbs
November 2021
- Opinion
- Chanticleer
What we learnt: 10 tales of supply chain woe
Amid a barrage of AGM speeches and results, supply chain pain was easy to see. And most firms aren’t quite sure when it will end.
- Updated
- James Thomson
Investors give cold shoulder to Nufarm’s return to profit
The farm chemicals group’s revenue and profit surged in its full-year results, but the share price fell 7.57 per cent to $4.64.
- Elouise Fowler
May 2021
Nufarm sees green shoots in aftermath of drought
The farm chemical supplier is reaping the benefits of the end in drought in Australia.
- Brad Thompson
Sharemarket at the whim of inflation fears
Equity markets will be at the whim of inflation fears, at least in the short-term, as investors try to position amid an uncertain outlook on just how central banks could respond to a rise in consumer prices.
- William McInnes
December 2020
The steady bloom of Australia's canna-biz
Amid the pandemic the medicinal marijuana industry is approaching maturation, as bankers and regulators cautiously take a toke.
- Aleks Vickovich and Carrie LaFrenz